The role of chemokines and chemokine receptors in diabetic nephropathy.
about
Induction of chemokine expression by adiponectin in vitro is isoform dependentCelastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db miceEffects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic NephropathyInflammation gene variants and susceptibility to albuminuria in the U.S. population: analysis in the Third National Health and Nutrition Examination Survey (NHANES III), 1991-1994Opposite action of peroxisome proliferator-activated receptor-gamma in regulating renal inflammation: functional switch by its ligandPatients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjectsImproved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysisCommon variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians.Nuclear NF-κB p65 in peripheral blood mononuclear cells correlates with urinary MCP-1, RANTES and the severity of type 2 diabetic nephropathy.Serum levels of the Th1 chemoattractant interferon-gamma-inducible protein (IP) 10 are elevated in patients with essential hypertension.Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice.Inhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signalingThe proximal tubule in the pathophysiology of the diabetic kidney.Serum amyloid A and inflammation in diabetic kidney disease and podocytes.High glucose induces CCL20 in proximal tubular cells via activation of the KCa3.1 channelAssociation of a Large Panel of Cytokine Gene Polymorphisms with Complications and Comorbidities in Type 2 Diabetes Patients.Integrated Haematological Profiles of Redox Status, Lipid, and Inflammatory Protein Biomarkers in Benign Obesity and Unhealthy Obesity with Metabolic Syndrome.Diabetic nephropathy in Africa: A systematic review.Expression and Role of CD166 in the Chronic Kidney Disease.Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system.A glimpse of various pathogenetic mechanisms of diabetic nephropathy.Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic miceUrinary biomarkers for sensitive and specific detection of acute kidney injury in humans.Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.Levels of inflammatory cytokines in type 2 diabetes patients with different urinary albumin excretion rates and their correlation with clinical variables.Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway.Fibrogenesis in kidney transplantation: potential targets for prevention and therapy.Antifibrotic treatment and other new strategies for improving renal outcomesPathophysiology of the diabetic kidney.Microinflammation in the pathogenesis of diabetic nephropathy.Role of the potassium channel KCa3.1 in diabetic nephropathy.KATP channels in high glucose-induced rat mesangial cell proliferation and release of MMP-2 and fibronectinDual CCR2/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice.Ursolic Acid provides kidney protection in diabetic ratsCTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB.Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease.Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice.Exendin-4 attenuates renal tubular injury by decreasing oxidative stress and inflammation in streptozotocin-induced diabetic mice.Structural refinement and prediction of potential CCR2 antagonists through validated multi-QSAR modeling studies.
P2860
Q24338189-EF34548F-86DB-4B14-A927-1BB672462205Q27323293-AD942C59-9C9C-4FBA-82A1-3FF34364B7CDQ28080888-AAB13174-DC62-430E-8686-8F9A92228EA5Q28384803-097CC9DA-C0A7-4AF2-85D3-77E259D2C5AEQ28581020-C913BEAF-6ACB-4EFD-BCFC-6D7A4E42E232Q30318873-E7C0D039-C060-427C-9D4E-D837C2B07049Q31171322-D5533C0E-F362-490C-BDD3-0E42818E2343Q33428547-6B5846FF-B20F-4E04-A1EC-6FE62241EBBFQ33768914-724DD239-7EEB-474C-A951-C4A105F6035DQ33791834-0E541F31-4855-43B0-930B-3ECAFE702112Q34552269-A2A504FC-7F43-4495-91C5-12AD0C7758F6Q34597496-99E259E0-D2DC-4B0A-A72C-19C89DA8C733Q34606146-096A979F-C0EE-4DB2-9135-9688D36A9DFDQ34979592-B3CA9172-C433-46E0-9DEE-C77EF672A26BQ35138098-3EF31CCB-7C19-44B9-8729-9D48609B6DEAQ35147905-BDA38E64-C478-4D64-A144-62AD79C19334Q35625900-C869DA29-4F23-4D02-8689-AC030011C870Q35673707-00F91B83-69EB-434B-80E2-AFDCBC064BFBQ35691399-0EBECD7D-7F49-40BF-AE74-6C521AF6F23AQ36175628-C1A34BB9-C3D4-4660-ABB3-87B5AF8CEB89Q36328641-54B77A5D-1CB7-4EC7-AD16-08BD6FABA297Q36979205-E926158E-E07F-46B7-80F4-F5898D9671C1Q37030987-A0345F7F-3997-4E44-90C3-9CCF5D3A1FFEQ37088937-D7064B9C-2CDF-488B-82D0-E7231B95A81DQ37253944-7E57D20C-F30F-4097-8C39-BAFC1C1AAA0DQ37358887-786CE5BF-87B2-4C3F-B531-309E3B2A2C28Q37408117-A7CB613C-554F-4504-9EE4-CC477661A893Q37638064-497BDE3F-7D08-428A-B385-866739854C2EQ37887401-D7706402-A93D-4E70-A512-72A31DA14928Q38111707-E185309D-135F-4DED-97B2-8B668D51724FQ38213048-99470D32-14C6-4CA8-8500-559204ACB722Q38223110-8EB9F5DC-D15B-443B-B351-9F9C1A3D4A5BQ38695983-41680ACA-76E0-41C7-A7A8-B9BE2544C5CAQ38884469-45DDB506-4443-4C07-87A7-ACC0525038C6Q39263724-168FE50E-EA51-49A2-A286-407F7A80BED1Q39855226-F8137CF7-C5AF-40BD-A34A-69697E1ADF20Q41854872-1FBEF1EC-CB91-4C66-B5BD-ED5E5F570D40Q45232179-8F4043F7-C83C-440D-B1DA-BB77C60C5803Q46615474-7C3B722A-D5C0-4070-9BC0-B637EA9AD306Q47282083-DF0CC620-EF8B-4F20-81D1-B6A05CE2B5D0
P2860
The role of chemokines and chemokine receptors in diabetic nephropathy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The role of chemokines and chemokine receptors in diabetic nephropathy.
@en
type
label
The role of chemokines and chemokine receptors in diabetic nephropathy.
@en
prefLabel
The role of chemokines and chemokine receptors in diabetic nephropathy.
@en
P356
P1476
The role of chemokines and chemokine receptors in diabetic nephropathy.
@en
P2093
Christiane Ruster
Gunter Wolf
P304
P356
10.2741/2734
P577
2008-01-01T00:00:00Z